Renaissance Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $31.6M | Sell |
87,346
-4,878
| -5% | -$1.67M | 1.28% | 31 |
|
|
2026
Q1 | $32.4M | Sell |
92,224
-20,658
| -18% | -$7.36M | 1.36% | 26 |
|
|
2025
Q4 | $36.9M | Buy |
112,882
+23,056
| +26% | +$7.31M | 1.48% | 17 |
|
|
2025
Q3 | $25.3M | Sell |
89,826
-16,136
| -15% | -$4.68M | 0.96% | 51 |
|
|
2025
Q2 | $29.6M | Buy |
+105,962
| New | +$30M | 1.15% | 51 |
|
|
2024
Q1 | – | Sell |
-990
| Closed | -$285K | – | 272 |
|
|
2023
Q4 | $285K | Buy |
990
+15
| +2% | +$4.09K | 0.01% | 241 |
|
|
2023
Q3 | $262K | Hold |
975
| – | – | 0.01% | 239 |
|
|
2023
Q2 | $216K | Buy |
975
+98
| +11% | +$22.7K | 0.01% | 261 |
|
|
2023
Q1 | $212K | Hold |
877
| – | – | 0.01% | 265 |
|
|
2022
Q4 | $230K | Sell |
877
-123
| -12% | -$33K | 0.01% | 259 |
|
|
2022
Q3 | $225K | Hold |
1,000
| – | – | 0.01% | 255 |
|
|
2022
Q2 | $243K | Sell |
1,000
-7
| -0.7% | -$1.72K | 0.01% | 255 |
|
|
2022
Q1 | $244K | Hold |
1,007
| – | – | 0.01% | 259 |
|
|
2021
Q4 | $227K | Hold |
1,007
| – | – | 0.01% | 265 |
|
|
2021
Q3 | $214K | Hold |
1,007
| – | – | 0.01% | 262 |
|
|
2021
Q2 | $245K | Sell |
1,007
-225
| -18% | -$55.4K | 0.01% | 263 |
|
|
2021
Q1 | $307K | Sell |
1,232
-2,711
| -69% | -$647K | 0.01% | 237 |
|
|
2020
Q4 | $907K | Buy |
3,943
+240
| +6% | +$55.3K | 0.04% | 166 |
|
|
2020
Q3 | $941K | Sell |
3,703
-627
| -14% | -$155K | 0.04% | 124 |
|
|
2020
Q2 | $1.02M | Sell |
4,330
-395
| -8% | -$90.1K | 0.05% | 119 |
|
|
2020
Q1 | $958K | Sell |
4,725
-978
| -17% | -$214K | 0.05% | 113 |
|
|
2019
Q4 | $1.38M | Buy |
5,703
+64
| +1% | +$14.1K | 0.06% | 112 |
|
|
2019
Q3 | $1.09M | Sell |
5,639
-319
| -5% | -$61.2K | 0.05% | 117 |
|
|
2019
Q2 | $1.1M | Buy |
5,958
+107
| +2% | +$19.2K | 0.04% | 116 |
|
|
2019
Q1 | $1.11M | Sell |
5,851
-38
| -0.6% | -$7.26K | 0.04% | 125 |
|
|
2018
Q4 | $1.15M | Sell |
5,889
-95
| -2% | -$18.5K | 0.05% | 120 |
|
|
2018
Q3 | $1.24M | Sell |
5,984
-654
| -10% | -$129K | 0.04% | 138 |
|
|
2018
Q2 | $1.23M | Sell |
6,638
-336
| -5% | -$59.4K | 0.04% | 137 |
|
|
2018
Q1 | $1.19M | Sell |
6,974
-184,235
| -96% | -$33.8M | 0.04% | 141 |
|
|
2017
Q4 | $33.3M | Sell |
191,209
-7,161
| -4% | -$1.27M | 1.12% | 37 |
|
|
2017
Q3 | $37M | Buy |
198,370
+5,541
| +3% | +$982K | 1.27% | 11 |
|
|
2017
Q2 | $33.2M | Sell |
192,829
-431
| -0.2% | -$70.1K | 1.22% | 18 |
|
|
2017
Q1 | $31.7M | Buy |
193,260
+9,415
| +5% | +$1.56M | 1.19% | 26 |
|
|
2016
Q4 | $26.9M | Sell |
183,845
-16,572
| -8% | -$2.49M | 1.09% | 45 |
|
|
2016
Q3 | $33.4M | Sell |
200,417
-6,108
| -3% | -$1.03M | 1.35% | 8 |
|
|
2016
Q2 | $31.4M | Sell |
206,525
-6,381
| -3% | -$992K | 1.32% | 10 |
|
|
2016
Q1 | $31.9M | Buy |
212,906
+9,379
| +5% | +$1.39M | 1.28% | 16 |
|
|
2015
Q4 | $33M | Buy |
203,527
+313
| +0.2% | +$49.2K | 1.3% | 17 |
|
|
2015
Q3 | $28.1M | Sell |
203,214
-1,470
| -0.7% | -$232K | 1.12% | 37 |
|
|
2015
Q2 | $31.4M | Buy |
204,684
+193,509
| +1,732% | +$31M | 1.2% | 32 |
|
|
2015
Q1 | $1.79M | Sell |
11,175
-201
| -2% | -$31.7K | 0.07% | 134 |
|
|
2014
Q4 | $1.81M | Sell |
11,376
-605
| -5% | -$94.3K | 0.07% | 134 |
|
|
2014
Q3 | $1.68M | Sell |
11,981
-971
| -7% | -$127K | 0.07% | 134 |
|
|
2014
Q2 | $1.53M | Sell |
12,952
-624
| -5% | -$72.2K | 0.06% | 143 |
|
|
2014
Q1 | $1.67M | Sell |
13,576
-373
| -3% | -$45.2K | 0.07% | 131 |
|
|
2013
Q4 | $1.59M | Sell |
13,949
-1,035
| -7% | -$118K | 0.06% | 133 |
|
|
2013
Q3 | $1.68M | Sell |
14,984
-744
| -5% | -$80.7K | 0.07% | 131 |
|
|
2013
Q2 | $1.55M | Buy |
+15,728
| New | +$1.63M | 0.07% | 132 |
|
Other funds holding AMGN
Renaissance Group's AMGN Position: Q2 2026 in Review
Renaissance Group reduced its Amgen (AMGN) stake by 5.3% in Q2 2026, selling an estimated $1.67M and leaving 87,346 shares worth $31.6M. The position accounts for 1.28% of the portfolio, ranked #31.
Renaissance Group first reported a position in AMGN in Q2 2013 and has held it in 48 quarters since. The position peaked at $37M in Q3 2017. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Renaissance Group held 87,346 shares of Amgen worth $31.6M as of Q2 2026.
- Renaissance Group sold 4,878 Amgen shares in Q2 2026, an estimated $1.67M.
- Amgen made up 1.28% of Renaissance Group's portfolio in Q2 2026, its #31 holding.
- Renaissance Group first reported a position in Amgen in Q2 2013 and has held it in 48 quarters since.
- Renaissance Group's Amgen position peaked at $37M in Q3 2017.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Renaissance Group's 13F filing for Q2 2026, filed 13 Aug 2026.